Adam Crowe

Adam Crowe

Company: Precision NanoSystems

Job title: Manager, Analytical Development


Analytical Insights Supporting the Development of a CoVID-19 saRNA LNP Vaccine 2:30 pm

• Precision NanoSystems Inc.’s (PNI) self-amplifying RNA (saRNA) offers numerous advantages over smaller mRNA payloads in SARS CoV2 LNP vaccines due to its low therapeutic dose and prolonged antigen expression in vivo; however, its size (>9000 nt) poses unique analytical challenges requiring innovation • Assessment of saRNA quality attributes including integrity, 5’ cap structure, and…Read more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.